Angiogenesis and immune supression: yin and yang of tumor progression?
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue
Abstract
Specialized variants of neoplastic cells that appear in tumors during cancer disease progression possess the ability to recruit certain kinds of hematopoietic and mesenchymal cells from the bone marrow or bloodstream. These tumor-recruited hematopoietic cells include monocytes, macrophages, granulocytes, mast and dendritic cells, as well as myeloblastic suppressor cells. Fibroblasts derived from undifferentiated mesenchymal cells are also recruited. Some of these cells (especially macrophages and fibroblasts) then undergo “education-like” phenotype reprogramming under the influence of the neoplastic cell population, resulting in the appearance of tumor-associated macrophages (TAM) and fibroblasts (CAF). Together with the extracellular matrix (ECM) as well with the remaining types of recruited cells, they contribute to the formation of a specific tumor microenvironment. Both the cells forming the tumor microenvironment and neoplastic cells engage in the two intimately linked processes of angiogenesis and immune suppression. The network of defective blood vessels formed during tumor angiogenesis and the resulting fluctuations in blood flow lead to under-oxygenation of the surrounding neoplastic cells and have substantial impact on their metabolic profile. A number of processes triggered in these under-oxygenated neoplastic cells appear to strongly favor further tumor progression. Such processes result in lower oxygen demand, enhanced angiogenesis, and epithelial-mesenchymal transition, owing to which the neoplastic cells acquire the ability to translocate. Under-oxygenation also leads to augmented genetic instability of the neoplastic cells. The tumor environment-forming cells also have their share in the establishment of an immunosuppressive environment which enables the neoplastic cells to escape immune surveillance. By providing a sophisticated milieu for the selection of increasingly malignant neoplastic cells (i.e. with proangiogenic and immunosuppressive phenotypes), the tumor microenvironment-forming cells substantially contribute to the progression of a neoplasm. Inhibited angiogenesis thus makes an immune response, both nonspecific and specific, possible. The remarks presented here may prove helpful in devising novel anticancer strategies involving antiangiogenic in combination with immunomodulatory drugs.
Authors and Affiliations
Stanisław Szala
Rola czynników prometastatycznych w rozwoju raka żołądka
Rak żołądka jest jedną z najczęstszych przyczyn zgonów spowodowanych chorobą nowotworową na świecie. Jest to związane z asymptomatycznym przebiegiem choroby w jej początkowym stadium, co znacznie opóźnia rozpoznanie, któ...
Immunoregulation by interference RNA (iRNA) – mechanisms, role, perspective
The functioning of an organism depends on the precise control mechanisms, constantly adjusted to the actual state. Therefore, there is a need for efficient communication between both adjacent and distant cells, which ma...
Angiotensin (1-7): A new link in the renin-angiotensin-aldosterone system (RAAS)
The discovery of a new angiotensin-converting enzyme (ACE2) and studies of the biological activity of angiotensin (1-7) indicate the complexity of the functioning of the renin-angiotensin-aldosterone system (RAAS). In th...
Drożdże jako model w badaniach chorób neurodegeneracyjnych
Drożdże piekarnicze Saccharomyces cerevisiae są najlepiej poznanymi na poziomie genetyki i fizjologii komórki organizmami eukariotycznymi. Konserwatyzm molekularnych mechanizmów komórkowych między drożdżami a człowieki...
Metabolism of endocannabinoids
Endocannabinoids belong to a group of ester, ether and amide derivatives of fatty acids, which are endogenous ligands of receptors CB1, CB2, TRPV1 and GPR55 that are included in the endocannabinoid system of the animal o...